Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.

Trial Profile

Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.

Suspended
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2016

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Chronic heart failure; Pulmonary hypertension
  • Focus Therapeutic Use
  • Acronyms SilHF
  • Most Recent Events

    • 20 Jul 2016 Planned number of patients changed from 210 to 120.
    • 20 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2017.
    • 20 Jul 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top